Please login to the form below

Pfizer/BioNTech

This page shows the latest Pfizer/BioNTech news and features for those working in and with pharma, biotech and healthcare.

Moderna vaccine given to first UK recipient in Wales

The Moderna vaccine will be administered in two doses, given between four and 12 weeks apart, in the same way as the Pfizer-BioNTech and Oxford-AstraZeneca vaccines that are already ... The Moderna vaccine can also be shipped at -20C, which is closer to

Latest news

Pfizer/BioNTech’s COVID-19 vaccine is 100% effective in adolescents

Pfizer and BioNTech’s mRNA-based COVID-19 vaccine has demonstrated 100% efficacy and safety in adolescents, including children as young as 12 years old. ... Pfizer and BioNTech added that the vaccine was also well tolerated, with side effects
CanSinoBIO considers booster jab for COVID-19 vaccine

mRNA-based vaccines, such as Pfizer/BioNTech and Moderna’s respective jabs, have higher efficacy rates compared to both CanSinoBIO and J&J’s vaccines, but also require ultra-low storage
BioNTech forecasts €9.8bn in sales of Pfizer-partnered COVID-19 vaccine in 2021

German biotech company BioNTech has forecast a significant 9.8bn for sales of its Pfizer-partnered COVID-19 vaccine in 2021. ... added. Pfizer and BioNTech are working on modified versions of their COVID-19 vaccine to address new variants of the
Single Pfizer/BioNTech dose induces strong immune response to COVID-19

A new study, conducted by researchers from Sheffield and Oxford Universities, has found that a single dose of the Pfizer/BioNTech vaccine induces a ‘robust’ immune response against COVID-19. ... The researchers found that 99% of people generated a
EMA recommends new manufacturing sites for COVID-19 vaccines

The CHMP has also recommended a new manufacturing site for Pfizer/BioNTech’s vaccine, located in the German city of Marburg. ... Originally, the Pfizer/BioNTech vaccine was required to be stored at a temperature between -90˚C to -60˚C in special

More from news
Approximately 49 fully matching, plus 96 partially matching documents found.

Latest Intelligence

Rare genetic diseases – what’s in store for 2021?

In the UK, the looming Brexit sparked new models of regulatory approval and fast-track opportunities, as recently observed in the rapid approval of Pfizer’s COVID-19 vaccine. ... So far the Pfizer/BioNTech, Moderna and AstraZeneca/Oxford University
Working together against COVID-19

Beyond the connection between HCPs and pharma or NGOs, it is encouraging to see collaborations such as Clover and GSK evaluating a vaccine candidate and Pfizer and Biontech doing the same. ... A number of top pharma companies are included in the newly

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

What does the COVID-19 vaccine mean for the future of R&D?

Both the Oxford/AstraZeneca and Pfizer/BioNTech vaccines were developed using platform technologies which didn’t exist 20 years ago, allowing these vaccines to be developed much faster.
The UK has approved the first vaccine for COVID-19. What now?

The authorisation of Pfizer/BioNtech's mRNA vaccine by the MHRA is great news, but no-one has ever tried to roll out a vaccine as rapidly as this one, so
Mistrust in medical research: a patient perspective

Health Products Regulatory Agency’s speedy approval of the Pfizer-BioNTech COVID-19 vaccine in the UK. ... A good example is a recent incident in the UK that made headline news, where two NHS workers who were among the first to receive the
Is the world ready for a COVID-19 vaccine?

At the beginning of November, Pfizer and BioNTech announced that their vaccine candidate was more than 90% effective at preventing COVID-19 infection. ... At the beginning of November, Pfizer and BioNTech announced that their vaccine candidate was more
Hanover Communications

At the beginning of November, Pfizer and BioNTech announced that their vaccine candidate was more than 90% effective at preventing COVID-19 infection.

More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Senior Content Editor - Biotechnology: Salary TBC

Principal Medical Writer: Varies on experience

Senior Leadership Role – Medical Communications – North West: Highly Competitive Salary, Bonus &Benefits

FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...: Highly Competitive Day Rate, Bonus &Benefits

Account Management: Competitive Salary Offered

Freelance Medical Writer - Creative Healthcare Comms - 2 month t...: Excellent Day Rate

Freelance Account Manager - Creative Healthcare Comms - Immediat...: Excellent Day Rate

Senior Account / Programme Manager - MedComms - Buckinghamshire: Highly Competitive Remuneration packages

PMHub

Add my company

Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

Virtual congresses: video thrilled the cardio tsar: Chris Ross explores the key learnings from a year of virtual congresses...
When Will We Be Back To Normal?: The definitive question of 2021, whether you’re a homeschooling parent, a homebound professional, a wanderer with nowhere to go… or all three at once....
How to tell your healthcare story.: Healthcare research is not a simple story and the people in charge of those moments need to be careful about the story that they tell....